Atta Behfar

@AttaBehfar

Regenerative Medicine and Heart Transplant at Mayo Clinic
Founder of Rion Inc.

Minnesota, USA Joined May 2018

44 Following 275 Followers 19 Posts

Latest posts 5

Atta Behfar @AttaBehfar Jun 4, 2024

Excited to share this case report of PEP curing a non-healing radiation wound. Tremendous testament of Dr. Van Able's dedication to her patients and the Rion team's work to provide PEP exosomes for this clinical effort.

nam12.safelinks.protection.outlook.com/?url=https%3A%…

Atta Behfar @AttaBehfar May 14, 2024

A tremendous effort by many colleagues over 1 decade and spanning 2 continents to establish this paradigm - congratulations to the whole team!!

Sara Inglis @SaraInglisMBBCh May 6, 2024

Privileged to be part of this exciting work @MayoClinicCV

Check out our recent article @JAHA_AHA

ahajournals.org/doi/10.1161/JA…

#Infliximab-mediated immune modulation limits injury in a porcine model of #MI

View quoted post on X

Atta Behfar @AttaBehfar Jan 2, 2024

Excited to highlight Rion's disruptive exosome technology with a global audience. businesswire.com/news/home/2024…

www.businesswire.com Rion to Present at the 42nd Annual J.P. Morgan Healthcare Conference Rion, a leader in regenerative medicine and exosome technology, today announced Dr. Atta Behfar, Co-Founder, will present at the 42nd Annual JP Morgan Health...

Atta Behfar @AttaBehfar Apr 28, 2021

Democratizing regenerative medicine through development of room temperature stable exosomes

Atta Behfar @AttaBehfar Apr 28, 2021

newsnetwork.mayoclinic.org/discussion/may…

newsnetwork.mayoclinic.org Mayo Clinic preclinical discovery triggers wound healing, skin regeneration - Mayo Clinic News... ROCHESTER, Minn. — Difficult-to-treat, chronic wounds in preclinical models healed with normal scar-free skin after treatment with an acellular product discovered at Mayo Clinic. Derived from...